TrialTrials2022

Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial.

Anan Manomaipiboon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.